







Things started working when I was able to talk to a provider who had some experience with SERMs. They acknowledged that spironolactone wasn’t working for me, and prescribed leuprolide injections. They also said they had no experience with raloxifene, but had used tamoxifen, a different SERM, in a previous patient. This turned out to be a lucky coincidence for me, because on tamoxifen, I definitely did notice some estrogenic effects, but not in my breasts.
Translational Significance of Selective Estrogen Receptor Modulators in Psychiatric Disorders
Accumulating data from various clinical trial studies suggests that adjuvant therapy with ovarian hormones (estrogens) could be effective in reducing cognitive deficit and psychopathological symptoms in women with psychiatric disorders. However, estrogen therapy poses serious limitations and health issues including feminization in men and increased risks of thromboembolism, hot flashes, breast hyperplasia, and endometrium hyperplasia when used for longer duration in older women (aged ≥ 60 years) or in women who have genetic predispositions. On the other hand, selective estrogen receptor modulators (SERMs), which may (or may not) carry some risks of hot flashes, thromboembolism, breast hyperplasia, and endometrial hyperplasia, are generally devoid of feminization effect. In clinical trial studies, adjuvant therapy with tamoxifen, a triphenylethylene class of SERM, has been found to reduce the frequency of manic episodes in patients with bipolar disorder, whereas addition of raloxifene, a benzothiophene class of SERM, to regular doses of antipsychotic drugs has been found to reduce cognitive deficit and psychological symptoms in men and women with schizophrenia, including women with treatment refractory psychosis. These outcomes together with potent neurocognitive, neuroprotective, and cardiometabolic properties suggest that SERMs could be the potential targets for designing effective and safer therapies for psychiatric disorders.

A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy
A Review of Selective Estrogen Receptor Modulators and their Potential for Transfeminine Hormone Therapy by Lain

Overview of feminizing hormone therapy | Gender Affirming Health Program
The goal of feminizing hormone therapy is the development of female secondary sex characteristics, and suppression/minimization of male secondary sex characteristics. General effects include breast development (usually to Tanner stage 2 or 3), a redistribution of facial and body subcutaneous fat, reduction of muscle mass, reduction of body hair (and to a lesser extent, facial hair), change in sweat and odor patterns, and arrest and possible reversal of scalp hair loss. Sexual and gonadal effects include reduction in erectile function, changes in libido, reduced or absent sperm count and ejaculatory fluid, and reduced testicular size. Feminizing hormone therapy also brings about changes in emotional and social functioning. The general approach of therapy is to combine an estrogen with an androgen blocker, and in some cases a progestogen.
SERMs - QueerDoc • Trans Online Doctors Office - Curing LGBTQ+ Healthcare Discrimination
SERMs, or Selective Estrogen Receptor Modifiers, are medications initially designed to treat conditions such as infertility, breast cancer, and

Microdosing Estrogen
Learn about microdosing estrogen regimens and their effects from a quick guide to feminizing hormone therapy.

An Exploration of Possibilities for Hormone Therapy in Non-Binary Transfeminine People
An Exploration of Possibilities for Hormone Therapy in Non-Binary Transfeminine People by Aly

An Introduction to Hormone Therapy for Transfeminine People
An Introduction to Hormone Therapy for Transfeminine People by Aly

Progesterone Is Important for Transgender Women’s Therapy—Applying Evidence for the Benefits of Progesterone in Ciswomen
Current transgender women’s therapy is estradiol/antiandrogen. I suggest adding progesterone, given its antiandrogen, breast-feminizing, bone-formation, sl

Does anyone have experience with Non-binary specific HRT? In particular SERMs to prevent breast growth.
23 year old NB AMAB here! Anyone tried NB HRT for gender affirming care? There's very little research on the topic as of right now, so I was hoping…
Does anyone have experience with Non-binary specific HRT? In particular SERMs to prevent breast growth.
23 year old NB AMAB here! Anyone tried NB HRT for gender affirming care? There's very little research on the topic as of right now, so I was hoping…
Gender-affirming endocrine care for youth with a nonbinary gender identity
Nonbinary individuals, or those who identify outside of the traditional gender binary, are currently present in up to 9% of the general population of youth or up to 55% of gender-diverse youth. Despite the high numbers of nonbinary individuals, this population continues to experience barriers to healthcare due to providers’ inability to see beyond the transgender binary and lack of competence in providing nonbinary care. In this narrative review, we discuss using embodiment goals to individualize care of nonbinary individuals, and review hormonal and nonhormonal treatment options for gender affirmation. Hormonal treatments include those often used in binary transgender individuals, such as testosterone, estradiol, and anti-androgens, but with adjustments to dosing or timeline to best meet a nonbinary individual’s embodiment goals. Less commonly used medications such as selective estrogen receptor antagonists are also discussed. For nonhormonal options, alterations in gender expression such as chest binding, tucking and packing genitalia, and voice training may be beneficial, as well as gender-affirming surgeries. Many of these treatments lack research specific to nonbinary individuals and especially nonbinary youth, and future research is needed to ensure safety and efficacy of gender-affirming care in this population.

When Women Initiate Estrogen Therapy Matters | The Menopause Society
New large-scale analysis shows potential long-term benefits of initiating hormones during perimenopause

Menopausal hormone therapy and breast cancer: what is the evidence from randomized trials?
The relationship between menopausal hormone therapy (HT) and breast cancer is complex and further complicated by misinformation, perception, and overgeneralization of data. These issues are address...

E + Raloxifene 5 week update
20 votes, 13 comments. 135K subscribers in the TransDIY community. Questions and resources related to Hormone Replacement Therapy (HRT), for…
Gettin' Nerdy on Gettin' Curvy: Estradiol, Progesterone, and SERMs - QueerDoc • Trans Online Doctors Office - Curing LGBTQ+ Healthcare Discrimination
Estradiol, progesterone, and SERMs: what they do in the body and how we use them in gender affirming care for transgender folx.

Potential Side Effects of Gender-Affirming Hormone Therapy - QueerDoc • Trans Online Doctors Office - Curing LGBTQ+ Healthcare Discrimination
Research says 76.2% of patients want to know all possible side effects from a medication, but doctors only review some side effects 35% of the time with
